<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02673723</url>
  </required_header>
  <id_info>
    <org_study_id>FirstHAnhuiMU</org_study_id>
    <nct_id>NCT02673723</nct_id>
  </id_info>
  <brief_title>The Application of Docozine Combined With Sufentanil for Awake Tracheal Intubation</brief_title>
  <official_title>The Application of Docozine Combined With Sufentanil for Awake Tracheal Intubation—a Multiple Center, Randomized, Controlled，Double Blinded Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The First Affiliated Hospital of Anhui Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The First Affiliated Hospital of Anhui Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Mortality associated with difficult airway in anesthesia is up to 30%. So, it is urgent to
      find a safe and effective method for intubation. Awake tracheal intubation which is used to
      retain spontaneous breathing is one of the important measures to ensure the safety of the
      patients with difficult airway in anesthesia.

      Sufentanil is used to provide good analgesia and can effectively inhibit the reaction of
      awake tracheal intubation, however, the outstanding problem is serious respiratory depression
      after intravenous sufentanil injection. Few study showed that dezocine is a kappa opioid
      antagonist related to mild respiratory depression and can prevents sufentanil-induced cough
      during general anesthesia induction.It is necessary to carry out large-scale, multi-center,
      randomized, controlled clinical study to determine whether dezocine prevents
      sufentanil-induced respiratory depression and whether dezocine combined sufentanil is a safe
      and effective method for awake tracheal intubation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">February 2017</completion_date>
  <primary_completion_date type="Anticipated">February 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sedation assessment</measure>
    <time_frame>anesthesia induction</time_frame>
    <description>Observer's assessment of alertness/sedation(OAA/S) scale is used to assess the depth of sedation during anesthesia induction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The occurrence of cough response</measure>
    <time_frame>anesthesia induction</time_frame>
    <description>The cough scale is used to assess cough response the during anesthesia induction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The variation of blood pressure</measure>
    <time_frame>anesthesia induction</time_frame>
    <description>The variation of blood pressure（mmHg) during anesthesia induction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The variation of heart rate</measure>
    <time_frame>anesthesia induction</time_frame>
    <description>The variation of heart rate(bpm）during anesthesia induction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The variation of pulse oxygen saturation</measure>
    <time_frame>anesthesia induction</time_frame>
    <description>The variation of pulse oxygen saturation(%) during anesthesia induction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The occurrence of cardiovascular events</measure>
    <time_frame>from beginning of the anesthesia to the time the patients discharge, up to 3rd day after the surgery</time_frame>
    <description>The incidence of hypertension, hypotension, tachycardia and bradycardia from beginning of the anesthesia to the time the patients discharge, up to 3rd day after the surgery is recorded</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The occurrence of treatment-related adverse events</measure>
    <time_frame>from beginning of the anesthesia to the time the patients discharge, up to 3rd day after the surgery</time_frame>
    <description>The incidence of treatment-related adverse events as assessed by CTCAE v4.0</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Awake Tracheal Intubation</condition>
  <arm_group>
    <arm_group_label>Dezocine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dezocine（Dez A：0.05 mg/kg，Dez B：0.1 mg/kg and Dez C：0.15 mg/kg, diluted to 5 ml respectively) is given for 10 seconds after surface anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controlled</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>The same amount of saline is given for 10 seconds after surface anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Docozine</intervention_name>
    <description>dezocine（Dez A：0.05 mg/kg，Dez B：0.1 mg/kg and Dez C：0.15 mg/kg, diluted to 5 ml respectively) is given for 10 seconds after surface anesthesia</description>
    <arm_group_label>Dezocine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>The same amount of saline is given for 10 seconds after surface anesthesia</description>
    <arm_group_label>Controlled</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Written informed consent；

          2. Selective surgery and general anesthesia patients；

          3. Age 18-65 yrs；

          4. Anesthesia Society of American (ASA) Scale I~II；

        Exclusion Criteria:

          1. Mallampatis Ⅲ-Ⅳ；

          2. Heat rate &lt; 50 beats/minutes；

          3. II-III Atrioventricular block；

          4. Use of alpha agonist or antagonist within two weeks；

          5. Use of opioid within 24 hours；

          6. Serious heart, liver, kidney disease and cerebrovascular disease；

          7. Allergic to the trial drug and other anesthesia drug contraindication；

          8. Factors existed that affect language communication；

          9. Any respiratory disease；

         10. Unsuccessful intubation for 3 times or drop out during intubation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wei Er Gu, PhD,MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>First affiliated Hospital of Anhui Medical University Locations: China,</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Qi X Cheng, MD</last_name>
    <phone>13965015671</phone>
    <email>ch_xq1983@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Anqing Municipal Hospital</name>
      <address>
        <city>Anqing</city>
        <state>Anhui</state>
        <zip>231402</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xia Ju, MD</last_name>
    </contact>
    <investigator>
      <last_name>Bin S Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chaohu Affiliated Hospital of Anhui Medical University</name>
      <address>
        <city>Chaohu</city>
        <state>Anhui</state>
        <zip>238000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>xian Z Zha, MD</last_name>
    </contact>
    <investigator>
      <last_name>Qiong X Xia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Second Affiliated Hospital of Anhui Medical University</name>
      <address>
        <city>Hefei</city>
        <state>Anhui</state>
        <zip>230601</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rui Li, MD</last_name>
    </contact>
    <investigator>
      <last_name>Ye Zhang, PhD,MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The second People's Hospital of Wuhu</name>
      <address>
        <city>Wuhu</city>
        <state>Anhui</state>
        <zip>241000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jun Yin, MD</last_name>
    </contact>
    <investigator>
      <last_name>Bin X Liu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 23, 2016</study_first_submitted>
  <study_first_submitted_qc>February 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 4, 2016</study_first_posted>
  <last_update_submitted>February 21, 2017</last_update_submitted>
  <last_update_submitted_qc>February 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 23, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The First Affiliated Hospital of Anhui Medical University</investigator_affiliation>
    <investigator_full_name>Xinqi Cheng</investigator_full_name>
    <investigator_title>Clinical Professor of Anesthesia Department</investigator_title>
  </responsible_party>
  <keyword>docozine</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
    <mesh_term>Dezocine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

